U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446478) titled 'TIS for Improving Cognitive Impairment Associated With Schizophrenia' on Feb. 26.
Brief Summary: This study aims to evaluate the efficacy and safety of TIS targeting the hippocampus in ameliorating cognitive impairment associated with schizophrenia (CIAS). Participants will receive TIS twice a day for 2 weeks. Their clinical data, including the baseline clinical symptom scale score, cognitive function, and MRI data, will be collected at baseline and at the end of the 2-week intervention.
Study Start Date: March 15
Study Type: INTERVENTIONAL
Condition:
Cognitive Impairment Associated With Schizophrenia (CIAS)
Intervention:
DEVI...